CN108686096A - A kind of Chinese patent drug and preparation method thereof for treating coronary heart disease - Google Patents
A kind of Chinese patent drug and preparation method thereof for treating coronary heart disease Download PDFInfo
- Publication number
- CN108686096A CN108686096A CN201810940156.6A CN201810940156A CN108686096A CN 108686096 A CN108686096 A CN 108686096A CN 201810940156 A CN201810940156 A CN 201810940156A CN 108686096 A CN108686096 A CN 108686096A
- Authority
- CN
- China
- Prior art keywords
- parts
- coronary heart
- heart disease
- radix
- chinese patent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
The invention discloses a kind of Chinese patent drug and preparation method thereof for treating coronary heart disease, which includes the raw material of following parts by weight:10-30 parts of American Ginseng, 3-20 parts of safflower, 5-20 parts of cordyceps sinensis, 12-35 parts of lepidium seed, 15-40 parts of ching-chieh, 10-30 parts of prepared RHIZOMA PINELLIZE without adju-vant, 15-50 parts of Radix Astragali, 15-30 parts of Radix Glycyrrhizae, 50-100 parts of Radix Salviae Miltiorrhizae, 10-30 parts of menthol, 10-30 parts of ganoderma lucidum, 10-30 parts of tendril-leaved fritillary bulb, Radix Ophiopogonis 10-30 part.The Chinese patent drug of the present invention can qi-regulating promoting circulation of blood, it is living in stagnation resolvation, except the patch in blood, current twelve channels and collaterals improve the blood supply of the heart, brain.Cure mainly the diseases such as coronary heart diseases and angina pectoris, myocardial infarction, shortness of breath uncomfortable in chest, myocardial ischemia, cerebral ischemia.Inventive formulation carries out prescription by monarch principle, and all medicines share can effectively treat coronary heart disease.And the present invention is pure Chinese medicinal preparation, and it is safe to use, conveniently, it has no toxic side effect, raw material sources are extensive, with obvious effects, are the active drugs for treating coronary heart disease.
Description
Technical field
The present invention relates to a kind of Chinese patent drugs and preparation method thereof for treating coronary heart disease, belong to the field of Chinese medicines.
Background technology
Coronary heart disease is the abbreviation of coronary cardiopathy, is a kind of most common heart disease, refers to because coronary artery is narrow
Myocardial dysfunction and (or) organic disease caused by narrow, blood supply insufficiency, therefore also known as ischemic cardiomyopathy.Coronary heart disease is one
Kind myocardial ischemia-anoxemia caused by organic (the atherosclerosis or dynamic property vasopasm) stenosis or occlusion of coronary artery
The heart disease of (angina pectoris) or myocardial necrosis (myocardial infarction), also known as ischemic heart disease.The generation of coronary heart disease and coronary artery
The degree and number of atherosclerotic stenosis have a substantial connection, at the same with the diseases such as hypertension, diabetes and obesity,
Bad life habits etc. are to induce the principal element of the disease.Coronary heart disease is one of highest disease of the global death rate, currently, only I
State's patients with coronary heart disease is increased with 20% speed every year just more than 11,000,000 people, daily to have countless people to be preced with more
Worry annoyings.The treatment of coronary heart disease mainly has 3 kinds, is drug therapy, interventional treatment and coronary bypass surgery treatment respectively.Absolutely
Most patients with coronary heart disease is all carried out using drug therapy control coronary atherosclerosis to alleviate developing coronary heart disease, but
Clinically common many Western medicine have important meaning to heart toxic side effect, therefore for the Chinese medicine Therapy study of coronary heart disease
Justice.
Invention content
In view of the deficiencies of the prior art, the object of the present invention is to provide a kind of Chinese patent drug for treating coronary heart disease and its preparation sides
Method can effectively treat coronary heart disease.
To achieve the goals above, the technical solution adopted in the present invention is:
A kind of Chinese patent drug for treating coronary heart disease, includes the raw material of following parts by weight:10-30 parts of American Ginseng, safflower 3-20
Part, 5-20 parts of cordyceps sinensis, 12-35 parts of lepidium seed, 15-40 parts of ching-chieh, 10-30 parts of prepared RHIZOMA PINELLIZE without adju-vant, 15-50 parts of Radix Astragali, Radix Glycyrrhizae
15-30 parts, 50-100 parts of Radix Salviae Miltiorrhizae, 10-30 parts of menthol, 10-30 parts of ganoderma lucidum, 10-30 parts of tendril-leaved fritillary bulb, Radix Ophiopogonis 10-30 part.
A kind of preparation method of Chinese patent drug that treating coronary heart disease:After each raw material is crushed, mix by weight, and be packed into sky
In heart-soothing capsule, capsule is made.
Tablet, pulvis, granule, decoction is also made in the Chinese patent drug.
The pharmacology of above-mentioned each raw material is as follows:
American Ginseng, bitter, micro-sweet are cold in nature.The thoughts of returning home, lung, kidney channel.Boosting qi and nourishing yin relieves inflammation or internal heat and promotes the production of body fluid.Lack gas, mouth for polydipsia
Dry tongue is dry, phlegm blood of breathing with cough.
Safflower, it is sweet in flavor, it is mild-natured.Converge to heart and liver channels.Promoting menstruation promoting blood circulation and removing blood stasis, removing pattogenic heat from the blood and toxic material from the body.For Amenorrhea lump in the abdomen lump in the abdomen, the postpartum stasis of blood
Resistance, febrile virulent maculae, melancholy ruffian is bored, and palpitation with fear is gone mad.
Cordyceps sinensis, it is sweet in flavor, it is mild-natured.Return lung, kidney channel.Kidney tonifying benefit lung, hemostasis and phlegm.For chronic cough and dyspnea of deficiency type, overstrain cough is spat blood,
Impotence and seminal emission, soreness of waist and knee joint.
Lepidium seed, bitter, pungent, property Great Cold.Return lung, bladder warp.Removing heat from lung and relieving asthma, inducing diuresis for removing edema.It breathes with cough for phlegm heap soil or fertilizer over and around the roots, chest and abdomen
Ponding.
Ching-chieh, acrid flavour, slightly warm in nature.Return lung, Liver Channel.Inducing diaphoresis relieve heat, promoting eruption, disappear sore.For catching a cold, headache, measles, wind
Rash, sore from the beginning of.
Prepared RHIZOMA PINELLIZE without adju-vant, acrid flavour are warm-natured.Returns spleen, stomach, lung channel.It is eliminating dampness and eliminating phlegm.For damp-phlegm syndrome, gastral cavilty feeling of fullness, sputum is solidifying
It is poly-, it coughs up and can not spit.
Radix Astragali, it is sweet in flavor, it is warm-natured.Returns spleen, lung channel.Invigorating qi for strengthening superficies, pus draining and toxin expelling, diuresis, myogenic.For treatment deficiency of vital energy weak, long
Rush down the long disunion of rectal prolapse, spontaneous perspiration, oedema, sub-official prolapses, chronic rephrilis protinuria, diabetes, the open sore part.
Radix Glycyrrhizae, it is sweet in flavor, it is mild-natured.The thoughts of returning home, spleen, lung, stomach.It invigorates the spleen and benefits qi, moistens the lung and relieve the cough, it is clearing heat and detoxicating, alleviate analgesic, delays
And pharmacological property.
Radix Salviae Miltiorrhizae, bitter, cold nature.Converge to heart and liver channels.Promoting blood circulation, inducing meastruation to relieve menalgia, relieving restlessness that clears away heart-fire, cool blood to disappear carbuncle.For chest
Numbness is pained, gastral cavity abdomen hypochondriac pain, the accumulation of lump in the abdomen lump in the abdomen, hot numbness pain, dysphoria and insomnia, irregular menstruation, dysmenorrhoea Amenorrhea, sore swell and ache curative.
Menthol, it is acrid flavour, cool in nature.It is distributed in lung channel.Dispelling wind, heat-clearing.Main anemopyretic cold, headache, hot eyes, abscess of throat, dentalgia,
Pruitus.
Ganoderma lucidum, it is sweet in flavor, it is mild-natured.Return liver, lung, kidney channel.Invigorating qi for tranquilization, it is relieving cough and asthma.For dizziness egersis, palpitation,
Consumptive disease cough and asthma.
Tendril-leaved fritillary bulb, bitter, cold nature.Return lung, the heart channel of Hang-Shaoyin.Preventing phlegm from forming and stopping coughing, heat-clearing dissipating bind.For cough with lung heat, deficiency of Yin cough caused by dryness, carbuncle
It is swollen, scrofula.
Radix Ophiopogonis, sweet in flavor, slight bitter, cold nature.The thoughts of returning home, lung, stomach.Nourishing Yin and promoting production of body fluid, moistening lung clears away heart-fire.It is empty for dryness of the lung dry cough
Consumptive disease is coughed, injury thirst, vexed insomnia, Heat Diabetes, dry constipation of intestines, pharyngeal diphtheria.
In inventive formulation, American Ginseng, safflower, cordyceps sinensis, Radix Astragali, Radix Salviae Miltiorrhizae are monarch drug in a prescription altogether;Lepidium seed, prepared RHIZOMA PINELLIZE without adju-vant,
Tendril-leaved fritillary bulb is ministerial drug altogether;Ching-chieh, ganoderma lucidum are adjutant altogether;Radix Glycyrrhizae, menthol, Radix Ophiopogonis are to make medicine.
Advantageous effect of the present invention:
The Chinese patent drug of the present invention can qi-regulating promoting circulation of blood, it is living in stagnation resolvation, except the patch in blood, current twelve channels and collaterals, improve the heart,
The blood supply of brain.Cure mainly the diseases such as coronary heart diseases and angina pectoris, myocardial infarction, shortness of breath uncomfortable in chest, myocardial ischemia, cerebral ischemia.Inventive formulation
Prescription is carried out by monarch principle, all medicines share can effectively treat coronary heart disease.And the present invention is pure Chinese medicinal preparation, is used
Conveniently, safely, it has no toxic side effect, raw material sources are extensive, with obvious effects, are the active drugs for treating coronary heart disease.
Specific implementation mode
The specific implementation mode of the present invention is described in further detail with reference to embodiments.
Embodiment 1
A kind of Chinese patent drug for treating coronary heart disease, includes the raw material of following parts by weight:10 parts of American Ginseng, 3 parts of safflower, winter worm
5 parts of summer grass, 12 parts of lepidium seed, 15 parts of ching-chieh, 10 parts of prepared RHIZOMA PINELLIZE without adju-vant, 15 parts of Radix Astragali, 15 parts of Radix Glycyrrhizae, 50 parts of Radix Salviae Miltiorrhizae, menthol 10
Part, 10 parts of ganoderma lucidum, 10 parts of tendril-leaved fritillary bulb, 10 parts of Radix Ophiopogonis.
Preparation method is:After each raw material is crushed, mixes by weight, and be fitted into Capsules, capsule is made.
Embodiment 2
A kind of Chinese patent drug for treating coronary heart disease, includes the raw material of following parts by weight:20 parts of American Ginseng, 10 parts of safflower, winter
10 parts of worm summer grass, 20 parts of lepidium seed, 30 parts of ching-chieh, 20 parts of prepared RHIZOMA PINELLIZE without adju-vant, 30 parts of Radix Astragali, 20 parts of Radix Glycyrrhizae, 80 parts of Radix Salviae Miltiorrhizae, menthol
20 parts, 20 parts of ganoderma lucidum, 20 parts of tendril-leaved fritillary bulb, 20 parts of Radix Ophiopogonis.
Preparation method is:After each raw material is crushed, mixes by weight, and be fitted into Capsules, capsule is made.
Embodiment 3
A kind of Chinese patent drug for treating coronary heart disease, includes the raw material of following parts by weight:30 parts of American Ginseng, 20 parts of safflower, winter
20 parts of worm summer grass, 35 parts of lepidium seed, 40 parts of ching-chieh, 30 parts of prepared RHIZOMA PINELLIZE without adju-vant, 50 parts of Radix Astragali, 30 parts of Radix Glycyrrhizae, 100 parts of Radix Salviae Miltiorrhizae, peppermint
30 parts of brain, 30 parts of ganoderma lucidum, 30 parts of tendril-leaved fritillary bulb, 30 parts of Radix Ophiopogonis.
Preparation method is:After each raw material is crushed, mixes by weight, and be fitted into Capsules, capsule is made.
The instructions of taking of Chinese patent drug of the present invention is:2 times a day, 5 capsules, every anther sac contain 1.5g Chinese patent drug originals every time
Material, warm water take.A month as a treatment course, one to three course for the treatment of can be almost recovered, and model case is as follows:
Case 1:Zhang, man 76 years old, live Zhengzhou City Henan Province pipe city, and in October, 2017 burst is nervous to feel bad, the heart
Angina is diagnosed as burst myocardial inyaretion on inspection, and heart ischemia, symptom just has apparent slow on the day of taking the Chinese patent drug of the present invention
Solution, physical condition improves significantly after taking 20 days, continuously takes after two months, checks the display recovery from illness of heart radiography, follow-up is so far
Without recurrence.
Case 2:It is honest and just so-and-so, man 52 years old, lives Henan Province Tongxu County.It checks and makes a definite diagnosis with myocardial infarction through hospital, with
Shortness of breath uncomfortable in chest, nervous to feel bad, not easypro etc. symptoms of pareordia.Start in October, 2016 to take Chinese patent drug of the invention, takes two
Symptom disappears substantially after month, checks and is almost recovered to hospital, continues to take Chinese patent drug of the present invention after treatment in two months recovery from illness, with
It visits so far without recurrence.
Case 3:Zhang, man, 68 years old, lives Henan Province Minquan County.Menophania hospital in 2015, which checks, makes a definite diagnosis with high blood
Pressure, heart disease.Start to take the Chinese patent drug of the present invention in November, 2015, blood pressure is substantially steady after taking three months, heart without
Discomfort feeling, smooth breathing.In March, 2016, heart indices were normal, and follow-up is so far without recurrence through hospital's magnetic resonance examination.
Case 4:Liu, man, 69 years old, lives Henan Province Minquan County.Coronary heart disease is suffered from through hospital diagnosis more than 4 years, 2017
Year August starts to take the Chinese patent drug of the present invention, takes two after half a month, symptom disappears, without any uncomfortable feeling, through hospital
Check display recovery from illness, follow-up is so far without recurrence.
Case 5:Zhang, female 66 years old, live Henan Province Tongxu County.It is checked through hospital in December, 2017 and suffers from coronary heart disease,
Hospital suggests doing coronary artery stent implantation.Start in January, 2018 to take Chinese patent drug of the invention, takes symptom after two weeks
It is clearly better, is almost recovered again through hospital's check after continuously taking one month, indices are normal, coronal dynamic without carrying out
Arteries and veins Stent.
Case 6:So-and-so is made pottery, man 54 years old, lives Jiangsu Province Lianyungang.It is made a definite diagnosis with hat through hospital's CT examination within 2013
Worry, not timing have angina pectoris, the symptoms such as shortness of breath uncomfortable in chest, hospital to suggest doing coronary artery stent implantation.In March, 2014 starts
The Chinese patent drug for taking the present invention, after three months, symptom disappears, and carrying out check display in hospital is almost recovered, and indices are basic
Normally, without carrying out coronary artery stent implantation, so far, patient lives normally over 4 years, without any uncomfortable sense for follow-up
Feel.
The foregoing is merely the embodiments that the present invention is best, and for those skilled in the art, the present invention can have
Various modifications and variations.All within the spirits and principles of the present invention, any modification, equivalent replacement, improvement and so on, should all
It is included within protection scope of the present invention.
Claims (6)
1. a kind of Chinese patent drug for treating coronary heart disease, which is characterized in that include the raw material of following parts by weight:10-30 parts of American Ginseng is hidden
3-20 parts of safflower, 5-20 parts of cordyceps sinensis, 12-35 parts of lepidium seed, 15-40 parts of ching-chieh, 10-30 parts of prepared RHIZOMA PINELLIZE without adju-vant, Radix Astragali 15-50
Part, 15-30 parts of Radix Glycyrrhizae, 50-100 parts of Radix Salviae Miltiorrhizae, 10-30 parts of menthol, 10-30 parts of ganoderma lucidum, 10-30 parts of tendril-leaved fritillary bulb, Radix Ophiopogonis 10-30
Part.
2. the Chinese patent drug for the treatment of coronary heart disease according to claim 1, which is characterized in that include the raw material of following parts by weight:
It is 10 parts of American Ginseng, 3 parts of safflower, 5 parts of cordyceps sinensis, 12 parts of lepidium seed, 15 parts of ching-chieh, 10 parts of prepared RHIZOMA PINELLIZE without adju-vant, 15 parts of Radix Astragali, sweet
15 parts of grass, 50 parts of Radix Salviae Miltiorrhizae, 10 parts of menthol, 10 parts of ganoderma lucidum, 10 parts of tendril-leaved fritillary bulb, 10 parts of Radix Ophiopogonis.
3. the Chinese patent drug for the treatment of coronary heart disease according to claim 1, which is characterized in that include the raw material of following parts by weight:
20 parts of American Ginseng, 10 parts of safflower, 10 parts of cordyceps sinensis, 20 parts of lepidium seed, 30 parts of ching-chieh, 20 parts of prepared RHIZOMA PINELLIZE without adju-vant, 30 parts of Radix Astragali,
20 parts of Radix Glycyrrhizae, 80 parts of Radix Salviae Miltiorrhizae, 20 parts of menthol, 20 parts of ganoderma lucidum, 20 parts of tendril-leaved fritillary bulb, 20 parts of Radix Ophiopogonis.
4. the Chinese patent drug for the treatment of coronary heart disease according to claim 1, which is characterized in that include the raw material of following parts by weight:
30 parts of American Ginseng, 20 parts of safflower, 20 parts of cordyceps sinensis, 35 parts of lepidium seed, 40 parts of ching-chieh, 30 parts of prepared RHIZOMA PINELLIZE without adju-vant, 50 parts of Radix Astragali,
30 parts of Radix Glycyrrhizae, 100 parts of Radix Salviae Miltiorrhizae, 30 parts of menthol, 30 parts of ganoderma lucidum, 30 parts of tendril-leaved fritillary bulb, 30 parts of Radix Ophiopogonis.
5. a kind of preparation method of the Chinese patent drug for the treatment of coronary heart disease as described in claim 1-4, which is characterized in that by each raw material
It after crushing, mixes, and is fitted into Capsules by weight, capsule is made.
6. a kind of preparation method of the Chinese patent drug for the treatment of coronary heart disease as described in claim 1-4, which is characterized in that in described
Tablet, pulvis, granule, decoction is also made in patent medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810940156.6A CN108686096A (en) | 2018-08-17 | 2018-08-17 | A kind of Chinese patent drug and preparation method thereof for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810940156.6A CN108686096A (en) | 2018-08-17 | 2018-08-17 | A kind of Chinese patent drug and preparation method thereof for treating coronary heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108686096A true CN108686096A (en) | 2018-10-23 |
Family
ID=63841708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810940156.6A Pending CN108686096A (en) | 2018-08-17 | 2018-08-17 | A kind of Chinese patent drug and preparation method thereof for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108686096A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1239668A (en) * | 1998-06-19 | 1999-12-29 | 谢天方 | Oral liquid for treating cardiac and cerebral vascular diseases and promoting blood circulation and its preparation process |
| WO2017145056A1 (en) * | 2016-02-23 | 2017-08-31 | SINGH, Gurseet | Nicotine free herbal composition for smoking de-addiction and treatment of side-effects and/or ailments from smoking |
| CN107456481A (en) * | 2017-07-24 | 2017-12-12 | 玉林市中医医院 | A kind of Chinese medicine composition for treating coronary disease and angina pectoris and preparation method thereof |
-
2018
- 2018-08-17 CN CN201810940156.6A patent/CN108686096A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1239668A (en) * | 1998-06-19 | 1999-12-29 | 谢天方 | Oral liquid for treating cardiac and cerebral vascular diseases and promoting blood circulation and its preparation process |
| WO2017145056A1 (en) * | 2016-02-23 | 2017-08-31 | SINGH, Gurseet | Nicotine free herbal composition for smoking de-addiction and treatment of side-effects and/or ailments from smoking |
| CN107456481A (en) * | 2017-07-24 | 2017-12-12 | 玉林市中医医院 | A kind of Chinese medicine composition for treating coronary disease and angina pectoris and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 张肖力: "老年冠心病合并呼吸道感染治疗体会", 《天津中医》 * |
| 靳光荣: "益气通瘀汤治疗冠心病心绞痛42例 ", 《陕西中医学院学报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101618155B (en) | Medicine for curing oral mucosal disease | |
| CN103550517B (en) | A kind of medicine of Hepatoma therapy | |
| CN102342992B (en) | Chinese medicinal composition for treating insomnia and preparation method of preparation thereof | |
| CN100571748C (en) | A kind of Chinese medicine composition of orally taken for curing hyperthyroidism | |
| CN104547790A (en) | Traditional Chinese medicine composition for treating rheumatic arthritis and preparation method thereof | |
| CN103623358B (en) | A kind of Chinese medicine decoction for the treatment of acute, chronic pharyngitis | |
| CN104399009A (en) | Traditional Chinese medicine formula for treating liver cancer and preparation method adopting traditional Chinese medicine formula | |
| CN103432559A (en) | Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof | |
| CN103142895B (en) | Kidney nourishing mixture and preparation method thereof | |
| CN104383317A (en) | Chinese traditional medicine composition for treating liver cancer | |
| CN101401914B (en) | Medicine for treating hyperplasia of mammary glands | |
| CN103565929B (en) | Traditional Chinese medicine combination for treating heart blood deficiency type night sweat | |
| CN101129841A (en) | Traditional Chinese medicine composition for treating self-output of latex | |
| CN104623148A (en) | Medicament for treating cough and asthma and preparation method of oral liquid thereof | |
| CN104623583A (en) | Asthenia cold abdominalgia treating drug and preparation method of asthenia cold abdominalgia treating drug oral liquid | |
| CN103599430B (en) | A kind of Chinese medicine composition being used for the treatment of cardiac asthma | |
| CN108686096A (en) | A kind of Chinese patent drug and preparation method thereof for treating coronary heart disease | |
| CN104474455A (en) | Traditional Chinese medicine for treating hyperthyroidism | |
| CN104784559A (en) | Traditional Chinese medicine preparation for treating postcholecystectomy syndrome | |
| CN104547369A (en) | Oral medicine for treating blepharospasm and preparation method thereof | |
| CN103223107A (en) | Traditional Chinese medicine used for adjusting blood fat and blood pressure, and preparation technology thereof | |
| CN102240384B (en) | Medicament for treating phlegm-stasis accumulating type epilepsy and preparation method thereof | |
| CN101773605B (en) | Herbal wasting-thirst penetrant for treating diabetes | |
| CN101204496B (en) | Chinese patent medicine for irregular menstruation | |
| CN105853872A (en) | Novel traditional Chinese medicine composition for treating lassitude and asthenia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181023 |
|
| RJ01 | Rejection of invention patent application after publication |